Family-authored Digital ICU Diary Intervention to Support Bereaved Family Members in Intensive Care Unit: A Pilot Mixed Methods Study (ICU-Diary-HK)
Feasibility, Acceptability and Efficacy of a Family-authored Digital ICU Diary Intervention for Bereaved Family Members in Hong Kong Intensive Care Units: A Pilot Randomised Controlled Trial With Qualitative Process Evaluation
Objectives: To assess the feasibility, acceptability and appropriateness of a family-authored digital ICU diary intervention for bereaved family members in Hong Kong ICUs, and to explore family members' experiences of writing digital diaries during and following patient death.
Hypothesis: The ICU digital diary intervention will prove feasible, acceptable and potentially efficacious in reducing bereaved family members' PTSD, anxiety and depression at 1 and 3 months post-patient death compared with baseline measurements.
Design and Subjects: A two-arm, assessor-blind pilot randomised controlled trial with subsequent qualitative process evaluation. Forty family members of ICU patients receiving life-sustaining treatment will be recruited from three Hong Kong public hospitals and randomised 1:1 to intervention or control groups.
Instruments: Feasibility of Intervention Measure (FIM), Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), Impact of Event Scale-Revised (IES-R), Posttraumatic Stress Syndrome-14 (PTSS-14) and Hospital Anxiety and Depression Scale (HADS).
Intervention: Family-authored digital ICU diary via WhatsApp, commencing when a patient's treatment is deemed life-sustaining, continuing through death and a one-month bereavement period.
Main Outcome Measures: Primary: recruitment rate, retention rate, compliance, feasibility, acceptability and appropriateness. Secondary: symptoms of PTSD, anxiety and depression.
Data Analysis: Descriptive statistics for feasibility outcomes; repeated measures ANOVA and linear mixed effects models for psychological outcomes; thematic analysis for qualitative data.
연구 개요
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Hye Ri Choi
- 전화번호: 852-6349-0524
- 이메일: hyeripc@hku.hk
참여기준
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
설명
Inclusion Criteria:
- One family member (closest to patient: spouse, grown child, or parent) of adult ICU patients whose treatment is considered life-sustaining
- Patient admitted to adult ICU for minimum 48 hours
- Patient dies in adult ICU without transfer to other inpatient units
- Able to read, write and communicate effectively in Chinese or English
Exclusion Criteria:
- Currently diagnosed with psychiatric disease and taking psychotropic medication
- Currently participating in any psychological intervention
- Cognitive impairment
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 건강 서비스 연구
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 하나의
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: 간섭
|
From medical consideration of life-sustaining treatment through patient death + 1 month post-death (approximately 4 weeks active writing, then wound down)
Standard care without the digital ICU diary intervention
|
|
활성 비교기: 제어
|
Standard care without the digital ICU diary intervention
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Feasibility of the Digital ICU Diary Intervention
기간: Month 1 and Month 3 after patient's death
|
Feasibility assessed using the Feasibility of Intervention Measure (FIM), a 4-item, 5-point Likert scale (1=Completely disagree to 5=Completely agree).
Higher scores indicate greater perceived feasibility.
|
Month 1 and Month 3 after patient's death
|
|
Acceptability of the Digital ICU Diary Intervention
기간: Month 1 and Month 3 after patient's death
|
Acceptability assessed using the Acceptability of Intervention Measure (AIM), a 4-item, 5-point Likert scale (1=Completely disagree to 5=Completely agree).
Higher scores indicate greater perceived acceptability.
|
Month 1 and Month 3 after patient's death
|
|
Appropriateness of the Digital ICU Diary Intervention
기간: Month 1 and Month 3 after patient's death
|
Appropriateness assessed using the Intervention Appropriateness Measure (IAM), a 4-item, 5-point Likert scale (1=Completely disagree to 5=Completely agree).
Higher scores indicate greater perceived appropriateness.
|
Month 1 and Month 3 after patient's death
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Post-Traumatic Stress Symptoms as Measured by the Impact of Event Scale-Revised (IES-R)
기간: Baseline, Month 1, and Month 3 after patient's death
|
IES-R, a 22-item self-report scale rated on a 5-point scale (0=not at all to 4=extremely).
Total score ranges from 0 to 88.
Higher scores indicate greater severity of post-traumatic stress symptoms.
|
Baseline, Month 1, and Month 3 after patient's death
|
|
Post-Traumatic Stress Symptoms as Measured by PTSS-14
기간: Baseline, Month 1, and Month 3 after patient's death
|
Posttraumatic Stress Syndrome-14 (PTSS-14), a 14-item self-report scale rated on a 7-point Likert scale (1=never to 7=always).
Total score ranges from 14 to 98. Higher scores indicate greater severity of post-traumatic stress symptoms.
|
Baseline, Month 1, and Month 3 after patient's death
|
|
Anxiety as Measured by the Hospital Anxiety and Depression Scale (HADS-A)
기간: Baseline, Month 1, and Month 3 after patient's death
|
HADS anxiety subscale, 7 items scored 0-3 each.
Subscale score ranges from 0 to 21.
Higher scores indicate greater severity of anxiety symptoms.
|
Baseline, Month 1, and Month 3 after patient's death
|
|
Depression as Measured by the Hospital Anxiety and Depression Scale (HADS-D)
기간: Baseline, Month 1, and Month 3 after patient's death
|
HADS depression subscale, 7 items scored 0-3 each.
Subscale score ranges from 0 to 21.
Higher scores indicate greater severity of depression symptoms.
|
Baseline, Month 1, and Month 3 after patient's death
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- HMRF23242771
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .